Last reviewed · How we verify

NCT06289907

Hot Flash and Night Sweat Virtual Study

Status unknown NA Last updated 4 March 2024
What this trial tests

NA trial testing Bonafide-HF3.0 in Menopause in 80 participants. Status unknown.

Timeline
9 July 2023
Primary endpoint
30 May 2024
30 July 2024

Quick facts

Lead sponsorBonafide Health
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment80
Start date9 July 2023
Primary completion30 May 2024
Estimated completion30 July 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Bonafide Health — full company profile →

Who can join

Adults 40 to 65, female only, with Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to evaluate the effectiveness of the study product on vasomotor symptoms (VMS) and overall menopause symptoms in healthy women, who are perimenopausal or postmenopausal, and aged 40 - 65.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Menopause

Currently open trials in the same condition.

Other Bonafide Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06289907.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing